KINS
Kingstone Companies, Inc.
KINS has a slight edge over MS overall, supported by stronger valuation.
MS
Morgan Stanley
MS has lower modeled downside risk, despite its lower overall score.
KINS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
KINS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like KINS.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
KINS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7x | $20.56 | -12% |
| Current | 7.9x | $23.23 | — |
| Forward | 8x | $23.23 | — |
| Fair | 11x | $30.94 | +33% |
| Expensive | 26x | $77.02 | +232% |
Historical ranges are pointers, not guarantees.
KINS has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
KINS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for KINS, but weaker profitability.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over KINS on the outlook, with more favorable valuation and profitability expectations.
KINS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.90 | -1% |
| Q3 2026 | $2.93 | +31% |
| Q2 2026 | $2.48 | +22% |
| Q1 2026 | $2.21 | +36% |
| Q4 2025 | $2.88 | +95% |
| Q3 2025 | $2.23 | +69% |
| Q2 2025 | $2.04 | +364% |
| Q1 2025 | $1.63 | +8050% |
| Q4 2024 | $1.48 | +$2.05 |
KINS's earnings per share have climbed steadily: $2.93 over the past year, up 31% from the year before, and higher year over year for 14 quarters in a row.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
KINS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $67.5M | +21% |
| Q2 2026 | $65.9M | +26% |
| Q1 2026 | $59.8M | +18% |
| Q4 2025 | $56.4M | +34% |
| Q3 2025 | $55.7M | +36% |
| Q2 2025 | $52.3M | +43% |
| Q1 2025 | $50.5M | +41% |
| Q4 2024 | $42.1M | +15% |
KINS has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 33% | +8.4 points |
| Q2 2026 | 30% | +2.5 points |
| Q1 2026 | -12% | -22 points |
| Q4 2025 | 33% | +17 points |
| Q3 2025 | 25% | +2.3 points |
| Q2 2025 | 27% | +11 points |
| Q1 2025 | 9.3% | +4.3 points |
| Q4 2024 | 16% | +5.2 points |
KINS has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
KINS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21M | -17% |
| Q2 2026 | $27.8M | +220% |
| Q1 2026 | $7.9M | -54% |
| Q4 2025 | $22.1M | -1.4% |
| Q3 2025 | $25.3M | +20% |
| Q2 2025 | $8.7M | +31% |
| Q1 2025 | $17M | +206% |
| Q4 2024 | $22.4M | +462% |
KINS has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
KINS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +44.5K shares |
| 1 year | +0.8% | +115K shares |
| 3 years | +37% | +4M shares |
| 5 years | +40% | +4.2M shares |
| Available history | +37% | +3.9M shares |
KINS has 15M diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $631,548 |
| Q2 2021 | $974,135 |
| Q1 2021 | $65,915 |
| Q4 2020 | $381,543 |
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over KINS on shareholder dilution, with a more favorable share count trend.
KINS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.5x | Net Cash |
| Q2 2025 | -0.8x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
KINS has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
KINS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.0 | Overbought |
| Stochastic | 87.0 | Overbought |
KINS's weekly RSI is 74 (overbought) and its Stochastic is 87 (overbought).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
KINS PE vs Financial Services Sector
| Metric | KINS | Sector median | Relative |
|---|---|---|---|
| PE | 7.9x | 13x | 39% below |
| PE % | 33 | 63 | 30 pts below |
KINS has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
KINS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $19.7 | 18% above |
| 20 week MA | $19.8 | 18% above |
| 50 week MA | $17.5 | 33% above |
| 100 week MA | $16.6 | 40% above |
| 200 week MA | $10.4 | 124% above |
KINS has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
KINS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.36 | $6.52 | -11% |
| 2021 | $6.52 | $4.99 | -23% |
| 2022 | $4.99 | $1.41 | -72% |
| 2023 | $1.41 | $2.13 | +51% |
| 2024 | $2.13 | $15.4 | +624% |
| 2025 | $15.4 | $17.3 | +12% |
| 2026 YTD | $17.3 | $23.2 | +34% |
KINS has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.